Organisations call for greater social impact of the European Commission’s medical research and innovation investments
Posted in category:
Statement
Published on:
Together with 22 civil society organisations, SOMO calls on the European Commission to seize the opportunity during the preparation of , to increase the social impact of its medical Research & Innovation investments and to generate more significant public return. The EC can do this by funding medical research and innovation projects that focus on unmet health needs and attaching access conditions to this funding so ensure public return on public investment.
Do you need more information?
-
Irene Schipper
Senior Researcher
Partners
-
Access to Medicines Ireland
-
Altroconsumo, associazione indipendente di consumatori (Italy)
-
BEUC – the European Consumer Organisation
-
BUKO Pharma-Kampagne (Germany)
-
Commons Network
-
EKPIZO – Consumer Association the Quality of Life (Greece)
-
EPHA- European Public Health Alliance
-
France Assos Santu00e9 (France)
-
Global Health Advocates
-
HAI – Health Action International
-
Just Treatment (UK)
-
Mu00e9dicins sans Frontiu00e8res Access Campaign
-
OCU – Organizaciu00f3n de Consumidores y Usuarios (Spain) 16. PRAKSIS
-
PRAKSIS (Greece)
-
Prescrire
-
Salud por Derecho (Spain)
-
SPARC Europe
-
STOPAIDS UK
-
Test-Aankoop/Test-Achats (Belgium)
-
Universities Allied for Essential Medicines (UAEM) – Europe
Download
Related news
-
EU health data law rolls out the red carpet for Big TechPosted in category:Long read
Irene SchipperPublished on: -
Civil society coalition urges EU to put the interests of patients and citizens at the heart of the European Health Data SpacePosted in category:Published on:Statement
-
